Crossref journal-article
Springer Science and Business Media LLC
Journal of Computer-Aided Molecular Design (297)
Bibliography

Diller, D. J., & Hobbs, D. W. (2007). Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation. Journal of Computer-Aided Molecular Design, 21(7), 379–393.

Authors 2
  1. David J. Diller (first)
  2. Doug W. Hobbs (additional)
References 79 Referenced 17
  1. Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R (2000) Cardiovasc Res 47:219 (10.1016/S0008-6363(00)00119-X) / Cardiovasc Res by W Haverkamp (2000)
  2. De Ponti F, Poluzzi E, Montanaro N (2000) Eur J Clin Pharmacol 56:1 (10.1007/s002280050714) / Eur J Clin Pharmacol by F De Ponti (2000)
  3. Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PKS, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG (2003) Cardiovasc Res 58:32 (10.1016/S0008-6363(02)00846-5) / Cardiovasc Res by WS Redfern (2003)
  4. Yap YG, Camm AJ (1999) Clin Exp Allergy 29:174 (10.1046/j.1365-2222.1999.0290s3174.x) / Clin Exp Allergy by YG Yap (1999)
  5. De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N (2002) Drug Saf 25:263 (10.2165/00002018-200225040-00004) / Drug Saf by F De Ponti (2002)
  6. Tang W, Kang J, Wu X, Rampe D, Wang L, Shen H, Li Z, Dunnington D, Garyantes T (2001) J Biomol Screen 6:325 (10.1177/108705710100600506) / J Biomol Screen by W Tang (2001)
  7. Rezazadeh S, Hesketh JC, Fedida D (2004) J Biomol Screen 9:588 (10.1177/1087057104264798) / J Biomol Screen by S Rezazadeh (2004)
  8. Cheng CS, Alderman D, Kwash J, Dessaint J, Patel R, Lescoe MK, Kinrade MB, Yu W (2002) Drug Dev Ind Pharm 28:177 (10.1081/DDC-120002451) / Drug Dev Ind Pharm by CS Cheng (2002)
  9. Chaudhary KW, O’Neal JM, Mo Z-L, Fermini B, Gallavan RH, Bahinski A (2006) Assay Drug Dev Technol 4:73 (10.1089/adt.2006.4.73) / Assay Drug Dev Technol by KW Chaudhary (2006)
  10. Finlayson K, Sharkey J (2004) In: Yan Z, Caldwell G (eds) Optimization in drug discovery. Humana Press, Totowa, NJ, pp353–368 (10.1385/1-59259-800-5:353)
  11. Finlayson K, Turnbull L, January CT, Sharkey J, Kelly JS (2001) Eur J Pharmacol 430:147 (10.1016/S0014-2999(01)01362-0) / Eur J Pharmacol by K Finlayson (2001)
  12. Diaz GJ, Daniell K, Leitza ST, Martin RL, Su Z, McDermott JS, Cox BF, Gintant GA (2004) J Pharmacol Toxicol Methods 50:187 (10.1016/j.vascn.2004.04.001) / J Pharmacol Toxicol Methods by GJ Diaz (2004)
  13. Chiu PJS, Marcoe KF, Bounds SE, Lin C-H, Feng J-J, Lin A, Cheng F-C, Crumb WJ, Mitchell R (2004) J Pharmacol Sci (Tokyo Japan) 95:311 / J Pharmacol Sci (Tokyo Japan) by PJS Chiu (2004)
  14. Witchel HJ, Milnes JT, Mitcheson JS, Hancox JC (2002) J Pharmacol Toxicol Methods 48:65 (10.1016/S1056-8719(03)00041-8) / J Pharmacol Toxicol Methods by HJ Witchel (2002)
  15. Lu HR, Vlaminckx E, Van Ammel K, De Clerck F (2002) Eur J Pharmacol 452:183 (10.1016/S0014-2999(02)02246-X) / Eur J Pharmacol by HR Lu (2002)
  16. Varro A, Balati B, Iost N, Takacs J, Virag L, Lathrop DA, Csaba L, Talosi L, Papp JG (2000) J Physiol 523:67 (10.1111/j.1469-7793.2000.00067.x) / J Physiol by A Varro (2000)
  17. Cavalli A, Poluzzi E, De Ponti F, Recanatini M (2002) J Med Chem 45:3844 (10.1021/jm0208875) / J Med Chem by A Cavalli (2002)
  18. Ekins S, Crumb WJ, Sarazan RD, Wikel JH, Wrighton SA (2002) J Pharmacol Exp Ther 301:427 (10.1124/jpet.301.2.427) / J Pharmacol Exp Ther by S Ekins (2002)
  19. Roche O, Trube G, Zuegge J, Pflimlin P, Alanine A, Schneider G (2002) Chembiochem 3:455 (10.1002/1439-7633(20020503)3:5<455::AID-CBIC455>3.0.CO;2-L) / Chembiochem by O Roche (2002)
  20. Keseru GM (2003) Bioorg Med Chem Lett 13:2773 (10.1016/S0960-894X(03)00492-X) / Bioorg Med Chem Lett by GM Keseru (2003)
  21. Pearlstein RA, Vaz RJ, Kang J, Chen X-L, Preobrazhenskaya M, Shchekotikhin AE, Korolev AM, Lysenkova LN, Miroshnikova OV, Hendrix J, Rampe D (2003) Bioorg Med Chem Lett 13:1829 (10.1016/S0960-894X(03)00196-3) / Bioorg Med Chem Lett by RA Pearlstein (2003)
  22. Aronov AM, Goldman BB (2004) Bioorg Med Chem 12:2307 (10.1016/j.bmc.2004.02.003) / Bioorg Med Chem by AM Aronov (2004)
  23. Du L-P, Tsai K-C, Li M-Y, You Q-D, Xia L (2004) Bioorg Med Chem Lett 14:4771 (10.1016/j.bmcl.2004.06.070) / Bioorg Med Chem Lett by L-P Du (2004)
  24. Zhang H, Hancox JC (2004) Biochem Biophys Res Commun 322:693 (10.1016/j.bbrc.2004.07.176) / Biochem Biophys Res Commun by H Zhang (2004)
  25. Aronov AM (2005) Drug Discov Today 10:149 (10.1016/S1359-6446(04)03278-7) / Drug Discov Today by AM Aronov (2005)
  26. Aronov AM (2006) J Med Chem 49:6917 (10.1021/jm060500o) / J Med Chem by AM Aronov (2006)
  27. Rajamani R, Tounge BA, Li J, Reynolds CH (2005) Bioorg Med Chem Lett 15:1737 (10.1016/j.bmcl.2005.01.008) / Bioorg Med Chem Lett by R Rajamani (2005)
  28. Farid R, Day T, Friesner RA, Pearlstein RA (2006) Bioorg Med Chem 14:3160 (10.1016/j.bmc.2005.12.032) / Bioorg Med Chem by R Farid (2006)
  29. Dixon SL, Merz KM Jr (2001) J Med Chem 44:3795 (10.1021/jm010137f) / J Med Chem by SL Dixon (2001)
  30. Wang N, DeLisle RK, Diller DJ (2005) J Med Chem 48:6980 (10.1021/jm050563r) / J Med Chem by N Wang (2005)
  31. Diller DJ, Lin TH, Metzger A (2005) Curr Top Med Chem 5:953 (10.2174/1568026054985948) / Curr Top Med Chem by DJ Diller (2005)
  32. Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss N, Pav S, Regan J (2002) Nat Struct Biol 9:268 (10.1038/nsb770) / Nat Struct Biol by C Pargellis (2002)
  33. Hall LH, Mohney B, Kier LB (1991) Quant Struct Act Relat 10:43 (10.1002/qsar.19910100108) / Quant Struct Act Relat by LH Hall (1991)
  34. Hall LH, Mohney B, Kier LB (1991) J Chem Inf Comput Sci 31:76 (10.1021/ci00001a012) / J Chem Inf Comput Sci by LH Hall (1991)
  35. Kier LB, Hall LH (1990) Pharm Res 7:801 (10.1023/A:1015952613760) / Pharm Res by LB Kier (1990)
  36. Hastie T, Tibshirani R, Friedman J (2001) The elements of statistical learning. Data mining, inference, and prediction. Springer-Verlag, New York / The elements of statistical learning. Data mining, inference, and prediction by T Hastie (2001)
  37. Press WH, Teulkolsky SA, Vetterling WT, Flannery BP (1997) Numerical recipes in C, 2 edn. Cambridge University Press, Cambridge, p 994 / Numerical recipes in C by WH Press (1997)
  38. Vapnik VN, (1999) Support vector method for function estimation, US05950146 (10.1007/978-1-4615-5703-6_3)
  39. Vapnik VN, Golowhich SE (2001) Support vector method for function estimation, US06269323
  40. Lynch JJ Jr, Wallace AA, Van der Gaag LH, Baskin EP, Bear CM, Gehret JR, Kothstein T, Stupienski RF, Appleby SD, Sanguinetti MC et al (1993) J Pharmacol Exp Ther 265:720 / J Pharmacol Exp Ther by JJ Lynch Jr (1993)
  41. Kongsamut S, Kang J, Chen X, Roehr J, Rampe D (2002) Eur J Pharmacol 450:37 (10.1016/S0014-2999(02)02074-5) / Eur J Pharmacol by S Kongsamut (2002)
  42. Rampe D, Murawsky MK, Grau J, Lewis EW (1998) J Pharmacol Exp Ther 286:788 (10.1016/S0022-3565(24)37654-2) / J Pharmacol Exp Ther by D Rampe (1998)
  43. Thomsen MB, Volders PGA, Stengl M, Spaetjens RLHMG, Beekman JDM, Bischoff U, Kall MA, Frederiksen K, Matz J, Vos MA (2003) J Pharmacol Exp Ther 307:776 (10.1124/jpet.103.052753) / J Pharmacol Exp Ther by MB Thomsen (2003)
  44. Beatch GN, Liu Y, Plouvier BMC (2001) Preparation of imidazo [1,2-a]pyridine ether compounds as ion channel modulators. Cardiome Pharma Corp., Canada, p 111 / Preparation of imidazo [1,2-a]pyridine ether compounds as ion channel modulators by GN Beatch (2001)
  45. Cooper LC, Carlson EJ, Castro JL, Chicchi GG, Dinnell K, Di Salvo J, Elliott JM, Hollingworth GJ, Kurtz MM, Ridgill MP, Rycroft W, Tsao K-L, Swain CJ (2002) Bioorg Med Chem Lett 12:1759 (10.1016/S0960-894X(02)00250-0) / Bioorg Med Chem Lett by LC Cooper (2002)
  46. Johnson RE, Silver PJ, Becker R, Birsner NC, Bohnet EA, Briggs GM, Busacca CA, Canniff P, Carabateas PM, Chadwick CC et al (1995) J Med Chem 38:2551 (10.1021/jm00014a008) / J Med Chem by RE Johnson (1995)
  47. Jurkiewicz NK, Wang J, Fermini B, Sanguinetti MC, Salata JJ (1996) Circulation 94:2938 (10.1161/01.CIR.94.11.2938) / Circulation by NK Jurkiewicz (1996)
  48. Valentin J-P, Hoffmann P, De Clerck F, Hammond TG, Hondeghem L (2004) J Pharmacol Toxicol Methods 49:171 (10.1016/j.vascn.2004.03.008) / J Pharmacol Toxicol Methods by J-P Valentin (2004)
  49. Mohammad S, Zhou Z, Gong Q, January CT (1997) Am J Physiol 273:H2534 / Am J Physiol by S Mohammad (1997)
  50. Rampe D, Roy ML, Dennis A, Brown AM (1997) FEBS Lett 417:28 (10.1016/S0014-5793(97)01249-0) / FEBS Lett by D Rampe (1997)
  51. Walker BD, Singleton CB, Bursill JA, Wyse KR, Valenzuela SM, Qiu MR, Breit SN, Campbell TJ (1999) Br J Pharmacol 128:444 (10.1038/sj.bjp.0702774) / Br J Pharmacol by BD Walker (1999)
  52. Carlsson L, Amos GJ, Andersson B, Drews L, Duker G, Wadstedt G (1997) J Pharmacol Exp Ther 282:220 (10.1016/S0022-3565(24)36775-8) / J Pharmacol Exp Ther by L Carlsson (1997)
  53. Drolet B, Khalifa M, Daleau P, Hamelin BA, Turgeon J (1998) Circulation 97:204 (10.1161/01.CIR.97.2.204) / Circulation by B Drolet (1998)
  54. Kang J, Wang L, Cai F, Rampe D (2000) Eur J Pharmacol 392:137 (10.1016/S0014-2999(00)00123-0) / Eur J Pharmacol by J Kang (2000)
  55. Selnick HG, Liverton NJ, Baldwin JJ, Butcher JW, Claremon DA, Elliott JM, Freidinger RM, King SA, Libby BE, McIntyre CJ, Pribush DA, Remy DC, Smith GR, Tebben AJ, Jurkiewicz NK, Lynch JJ, Salata JJ, Sanguinetti MC, Siegl PK, Slaughter DE, Vyas K (1997) J Med Chem 40:3865 (10.1021/jm970517u) / J Med Chem by HG Selnick (1997)
  56. Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT (1998) Biophys J 74:230 (10.1016/S0006-3495(98)77782-3) / Biophys J by Z Zhou (1998)
  57. Sanguinetti MC, Jurkiewicz NK (1990) J Gen Physiol 96:195 (10.1085/jgp.96.1.195) / J Gen Physiol by MC Sanguinetti (1990)
  58. Toyama J, Kamiya K, Cheng J, Lee JK, Suzuki R, Kodama I (1997) Circulation 96:3696 (10.1161/01.CIR.96.10.3696) / Circulation by J Toyama (1997)
  59. Ficker E, Jarolimek W, Kiehn J, Baumann A, Brown AM (1998) Circ Res 82:386 (10.1161/01.RES.82.3.386) / Circ Res by E Ficker (1998)
  60. Magyar J, Banyasz T, Bagi Z, Pacher P, Szentandrassy N, Fueloep L, Kecskemeti V, Nanasi PP (2002) Naunyn Schmiedebergs Arch Pharmacol 366:350 (10.1007/s00210-002-0595-1) / Naunyn Schmiedebergs Arch Pharmacol by J Magyar (2002)
  61. Waldegger S, Niemeyer G, Morike K, Wagner CA, Suessbrich H, Busch AE, Lang F, Eichelbaum M (1999) Cell Physiol Biochem 9:81 (10.1159/000016304) / Cell Physiol Biochem by S Waldegger (1999)
  62. Zhang S, Zhou Z, Gong Q, Makielski JC, January CT (1999) Circ Res 84:989 (10.1161/01.RES.84.9.989) / Circ Res by S Zhang (1999)
  63. Kamiya K, Nishiyama A, Yasui K, Hojo M, Sanguinetti MC, Kodama I (2001) Circulation 103:1317 (10.1161/01.CIR.103.9.1317) / Circulation by K Kamiya (2001)
  64. Kiehn J, Thomas D, Karle CA, Schols W, Kubler W (1999) Naunyn Schmiedebergs Arch Pharmacol 359:212 (10.1007/PL00005344) / Naunyn Schmiedebergs Arch Pharmacol by J Kiehn (1999)
  65. Taglialatela M, Pannaccione A, Castaldo P, Giorgio G, Zhou Z, January CT, Genovese A, Marone G, Annunziato L (1998) Mol Pharmacol 54:113 (10.1124/mol.54.1.113) / Mol Pharmacol by M Taglialatela (1998)
  66. Chachin M, Katayama Y, Yamada M, Horio Y, Ohmura T, Kitagawa H, Uchida S, Kurachi Y (1999) Eur J Pharmacol 374:457 (10.1016/S0014-2999(99)00375-1) / Eur J Pharmacol by M Chachin (1999)
  67. Suessbrich H, Waldegger S, Lang F, Busch AE (1996) FEBS Lett 385:77 (10.1016/0014-5793(96)00355-9) / FEBS Lett by H Suessbrich (1996)
  68. Snyders DJ, Chaudhary A (1996) Mol Pharmacol 49:949 / Mol Pharmacol by DJ Snyders (1996)
  69. Weerapura M, Hebert TE, Nattel S (2002) Pflugers Arch 443:520 (10.1007/s004240100720) / Pflugers Arch by M Weerapura (2002)
  70. Lees-Miller JP, Duan Y, Teng GQ, Duff HJ (2000) Mol Pharmacol 57:367 (10.1016/S0026-895X(24)23209-0) / Mol Pharmacol by JP Lees-Miller (2000)
  71. Geelen P, Drolet B, Rail J, Berube J, Daleau P, Rousseau G, Cardinal R, O’Hara GE, Turgeon J (2000) Circulation 102:275 (10.1161/01.CIR.102.3.275) / Circulation by P Geelen (2000)
  72. Crumb WJ Jr (2000) J Pharmacol Exp Ther 292:261 (10.1016/S0022-3565(24)35285-1) / J Pharmacol Exp Ther by WJ Crumb Jr (2000)
  73. Ko CM, Ducic I, Fan J, Shuba YM, Morad M (1997) J Pharmacol Exp Ther 281:233 (10.1016/S0022-3565(24)36589-9) / J Pharmacol Exp Ther by CM Ko (1997)
  74. Roy M, Dumaine R, Brown AM (1996) Circulation 94:817 (10.1161/01.CIR.94.4.817) / Circulation by M Roy (1996)
  75. Suessbrich H, Schonherr R, Heinemann SH, Attali B, Lang F, Busch AE (1997) Br J Pharmacol 120:968 (10.1038/sj.bjp.0700989) / Br J Pharmacol by H Suessbrich (1997)
  76. Chen J, Seebohm G, Sanguinetti MC (2002) Proc Natl Acad Sci USA 99:12461 (10.1073/pnas.192367299) / Proc Natl Acad Sci USA by J Chen (2002)
  77. Mitcheson J, Perry M, Stansfeld P, Sanguinetti MC, Witchel H, Hancox J (2005) Novartis Found Symp 266:136 (10.1002/047002142X.ch11) / Novartis Found Symp by J Mitcheson (2005)
  78. Jamieson C, Moir EM, Rankovic Z, Wishart G (2006) J Med Chem 49:5029 (10.1021/jm060379l) / J Med Chem by C Jamieson (2006)
  79. Eckhardt LL, Rajamani S, January CT (2005) Br J Pharmacol 145:3 (10.1038/sj.bjp.0706143) / Br J Pharmacol by LL Eckhardt (2005)
Dates
Type When
Created 18 years, 3 months ago (June 4, 2007, 6:31 a.m.)
Deposited 7 months, 3 weeks ago (Jan. 16, 2025, 5:16 p.m.)
Indexed 4 months, 4 weeks ago (April 8, 2025, 6:05 p.m.)
Issued 18 years, 3 months ago (June 5, 2007)
Published 18 years, 3 months ago (June 5, 2007)
Published Online 18 years, 3 months ago (June 5, 2007)
Published Print 18 years, 2 months ago (July 1, 2007)
Funders 0

None

@article{Diller_2007, title={Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation}, volume={21}, ISSN={1573-4951}, url={http://dx.doi.org/10.1007/s10822-007-9122-2}, DOI={10.1007/s10822-007-9122-2}, number={7}, journal={Journal of Computer-Aided Molecular Design}, publisher={Springer Science and Business Media LLC}, author={Diller, David J. and Hobbs, Doug W.}, year={2007}, month=jun, pages={379–393} }